A new trading day began on Tuesday, with PMV Pharmaceuticals Inc (NASDAQ: PMVP) stock price down -6.96% from the previous day of trading, before settling in for the closing price of $1.58. PMVP’s price has ranged from $0.81 to $1.84 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -14.06%. Meanwhile, its annual earnings per share averaged -36.84%. With a float of $42.55 million, this company’s outstanding shares have now reached $52.99 million.
PMV Pharmaceuticals Inc (PMVP) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of PMV Pharmaceuticals Inc is 19.71%, while institutional ownership is 60.18%. The most recent insider transaction that took place on Oct 23 ’25, was worth 1,520,000. In this transaction 10% Owner of this company sold 1,000,000 shares at a rate of $1.52, taking the stock ownership to the 4,975,291 shares. Before that another transaction happened on Oct 23 ’25, when Company’s Shareholder proposed sale 1,000,000 for $1.52, making the entire transaction worth $1,520,000.
PMV Pharmaceuticals Inc (PMVP) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.37 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.41 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -36.84% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -6.19% during the next five years compared to -14.06% drop over the previous five years of trading.
PMV Pharmaceuticals Inc (NASDAQ: PMVP) Trading Performance Indicators
Here are PMV Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 12.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.56, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -1.48 in one year’s time.
Technical Analysis of PMV Pharmaceuticals Inc (PMVP)
Looking closely at PMV Pharmaceuticals Inc (NASDAQ: PMVP), its last 5-days average volume was 1.13 million, which is a jump from its year-to-date volume of 0.52 million. As of the previous 9 days, the stock’s Stochastic %D was 57.87%.
During the past 100 days, PMV Pharmaceuticals Inc’s (PMVP) raw stochastic average was set at 58.93%, which indicates a significant increase from 45.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1080 in the past 14 days, which was higher than the 0.1039 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4150, while its 200-day Moving Average is $1.2528. However, in the short run, PMV Pharmaceuticals Inc’s stock first resistance to watch stands at $1.5300. Second resistance stands at $1.5900. The third major resistance level sits at $1.6400. If the price goes on to break the first support level at $1.4200, it is likely to go to the next support level at $1.3700. Should the price break the second support level, the third support level stands at $1.3100.
PMV Pharmaceuticals Inc (NASDAQ: PMVP) Key Stats
With a market capitalization of 77.90 million, the company has a total of 52,991K Shares Outstanding. Currently, annual sales are 0 K while annual income is -58,710 K. The company’s previous quarter sales were 0 K while its latest quarter income was -21,210 K.
